Keyword Analysis & Research: ticagrelor patent
Keyword Research: People who searched ticagrelor patent also searched
Search Results related to ticagrelor patent on Search Engine
Delhi High Court stops AstraZeneca’s attempts at
Generic Brilinta Availability - Drugs.com
DA: 96 PA: 16 MOZ Rank: 84
Ticagrelor | US Patents | Expiry | Expiration | Dates
Patent Expiration Date. 2021-07-09. Patent Use Code. U-1171. Delist Requested. Application Number. 22433. Patent Use Description. REDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME.
DA: 67 PA: 30 MOZ Rank: 100
WO2017072790A1 - Google Patents
The invention further discloses novel Polymorphic Form of Ticagrelor and its process for preparation thereof. WO2017072790A1 - An improved process for synthesis of ticagrelor - Google Patents An improved process for synthesis of …
DA: 51 PA: 69 MOZ Rank: 41
CN105055351A - Ticagrelor tablet composition - Google Patents
The invention relates to a ticagrelor tablet comprising ticagrelor and a pharmaceutically acceptable auxiliary material. Quality of the ticagrelor tablet is stable and controllable.
DA: 62 PA: 19 MOZ Rank: 25
US9233966B2 - Preparation of ticagrelor - Google Patents
US9233966B2 US14/389,669 US201314389669A US9233966B2 US 9233966 B2 US9233966 B2 US 9233966B2 US 201314389669 A US201314389669 A US 201314389669A US 9233966 B2 US9233966 B2 US 9233966B2 Authority US United States Prior art keywords compound formula ticagrelor acid mixture Prior art date 2012-04-05 Legal status (The legal status is an …
DA: 20 PA: 75 MOZ Rank: 8
Crystalline form of ticagrelor - Google Patents
A crystalline form of ticagrelor, designated as Form-AM, has a defined interplanar spacing as illustrated by Figure 1. WO2017118633A1 - Crystalline form of ticagrelor - Google Patents ... 2017-07-13 Publication of WO2017118633A1 publication Critical patent/WO2017118633A1/en Links. Espacenet;
DA: 64 PA: 66 MOZ Rank: 63
CN104744266A - Preparation method of ticagrelor
The invention discloses a preparation method of ticagrelor. The method comprises the following steps: (1) reducing a compound shown in a formula III in the presence of a proton source provided by sodium borohydride or potassium borohydride and diethyl aniline hydrochloride to obtain a compound shown in a formula IV; (2) reacting the compound IV in the presence of alkali to …
DA: 79 PA: 62 MOZ Rank: 48
Generic TICAGRELOR INN entry, pharmaceutical patent expiry
Sep 24, 2021 · Ticagrelor is the generic ingredient in two branded drugs marketed by Astrazeneca, Amneal, Hisun Pharm Hangzhou, Mylan, Sigmapharm Labs Llc, Sunshine, and Watson Labs Inc, and is included in seven NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the …
DA: 5 PA: 82 MOZ Rank: 93
BRILINTA Drug Patent Profile
Oct 07, 2021 · There are four patents protecting this drug and two Paragraph IV challenges. This drug has two hundred and twenty-five patent family members in forty-eight countries. The generic ingredient in BRILINTA is ticagrelor. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound.
DA: 76 PA: 61 MOZ Rank: 47
How is the invention of ticagrelor used in medicine?
Patent use: REDUCING THE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN A PATIENT RECEIVING 75-100 MG ASPIRIN DAILY AND HAVING OR WHO HAD ACUTE CORONARY SYNDROME BY ADMINISTERING 60 MG TICAGRELOR TWICE DAILY The invention provides new forms of a chemical compound of formula (I).
DA: 44 PA: 84 MOZ Rank: 47
Which is the crystalline form of ticagrelor?
A crystalline form of ticagrelor, designated as Form-AM, has a defined interplanar spacing as illustrated by Figure 1. WO2017118633A1 - Crystalline form of ticagrelor - Google Patents
DA: 16 PA: 99 MOZ Rank: 54
Is the quality of ticagrelor tablet controllable?
Quality of the ticagrelor tablet is stable and controllable. The invention relates to a ticagrelor tablet comprising ticagrelor and a pharmaceutically acceptable auxiliary material. Quality of the ticagrelor tablet is stable and controllable. CN105055351A - Ticagrelor tablet composition - Google Patents
DA: 94 PA: 54 MOZ Rank: 88
Is there a generic version of ticagrelor?
Brilinta is a brand name of ticagrelor, approved by the FDA in the following formulation (s): Has a generic version of Brilinta been approved? A generic version of Brilinta has been approved by the FDA.
DA: 12 PA: 67 MOZ Rank: 31